Biotechnology Stocks
242 US-listed companies in the Biotechnology industry, part of the Healthcare sector, ranked by market capitalisation. Open any ticker for quotes, charts, financials and analyst ratings.
Companies
242
Market cap
1.28T
P/E
23.3
Div yield
9.80%
Perf 1M
5.11%
Perf YTD
52.46%
All 242 Biotechnology stocks
| Ticker | Company | Price | Change | Market cap | P/E | Perf YTD |
|---|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 515.44 | 0.17% | 121.09B | 30.0 | 13.69% |
| REGN | Regeneron Pharmaceuticals, Inc. | 781.49 | -1.48% | 80.51B | 18.7 | 1.25% |
| ARGX | argenx SE | 984.39 | 0.04% | 61.60B | 35.9 | 17.06% |
| MRNA | Moderna, Inc. | 143.97 | 5.38% | 57.13B | — | 388.20% |
| RVMD | Revolution Medicines, Inc. | 203.77 | 0.21% | 43.32B | — | 155.83% |
| ONC | BeOne Medicines AG | 346.51 | 1.38% | 38.56B | 24.6 | 14.05% |
| ALNY | Alnylam Pharmaceuticals, Inc. | 248.68 | 0.47% | 33.28B | 40.8 | -37.46% |
| ROIV | Roivant Sciences Ltd. | 40.82 | -0.29% | 29.49B | — | 88.11% |
| INSM | Insmed Incorporated | 129.41 | 1.67% | 28.05B | — | -25.64% |
| INCY | Incyte Corporation | 121.47 | -1.47% | 24.62B | 14.9 | 22.98% |
| BNTX | BioNTech SE | 96.73 | 0.34% | 24.09B | — | 1.61% |
| UTHR | United Therapeutics Corporation | 497.11 | -1.34% | 21.10B | 16.4 | 2.02% |
| GMAB | Genmab A/S | 32.47 | 0.74% | 19.93B | 25.4 | 5.42% |
| ASND | Ascendis Pharma A/S | 263.52 | 0.88% | 16.37B | 18.8 | 23.58% |
| NBIX | Neurocrine Biosciences, Inc. | 156.22 | -0.22% | 15.71B | 22.2 | 10.15% |
| JAZZ | Jazz Pharmaceuticals plc | 245.80 | 2.21% | 15.44B | 16.2 | 44.59% |
| BBIO | BridgeBio Pharma, Inc. | 72.44 | -0.08% | 14.19B | — | -5.29% |
| EXEL | Exelixis, Inc. | 56.12 | -2.28% | 14.11B | 17.1 | 28.04% |
| SMMT | Summit Therapeutics Inc. | 17.55 | 3.24% | 14.00B | — | 0.34% |
| HALO | Halozyme Therapeutics, Inc. | 107.20 | 0.19% | 12.72B | 30.5 | 59.29% |
| BMRN | BioMarin Pharmaceutical Inc. | 65.68 | 0.26% | 12.69B | 172.8 | 10.52% |
| MDGL | Madrigal Pharmaceuticals, Inc. | 534.49 | 0.26% | 12.35B | — | -8.22% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 82.85 | 0.11% | 11.67B | — | 24.79% |
| AXSM | Axsome Therapeutics, Inc. | 220.75 | 4.56% | 11.36B | — | 20.87% |
| TECH | Bio-Techne Corporation | 72.12 | 0.06% | 11.29B | 61.6 | 22.63% |
| ABVX | Abivax S.A. | 118.64 | 2.32% | 10.24B | — | -12.02% |
| KRYS | Krystal Biotech, Inc. | 347.00 | 0.42% | 10.23B | 42.0 | 40.75% |
| PTGX | Protagonist Therapeutics, Inc. | 148.18 | 2.08% | 9.53B | 121.6 | 69.66% |
| KYMR | Kymera Therapeutics, Inc. | 114.96 | -1.74% | 9.46B | — | 47.74% |
| PRAX | Praxis Precision Medicines, Inc. | 334.58 | -1.18% | 9.33B | — | 13.52% |
| CYTK | Cytokinetics, Incorporated | 73.77 | 0.20% | 9.18B | — | 16.10% |
| NUVL | Nuvalent, Inc. | 123.96 | 0.00% | 9.13B | — | 23.23% |
| IONS | Ionis Pharmaceuticals, Inc. | 54.21 | -2.59% | 9.01B | — | -31.48% |
| CRNX | Crinetics Pharmaceuticals, Inc. | 84.95 | 0.00% | 9.00B | — | 82.49% |
| TXG | 10x Genomics, Inc. | 68.59 | 3.33% | 8.71B | — | 320.54% |
| PCVX | Vaxcyte, Inc. | 59.47 | 0.97% | 8.59B | — | 28.89% |
| APGE | Apogee Therapeutics, Inc. | 135.07 | -0.01% | 8.36B | — | 78.95% |
| IBRX | ImmunityBio, Inc. | 7.91 | 2.46% | 8.28B | — | 299.49% |
| TGTX | TG Therapeutics, Inc. | 53.89 | -2.71% | 8.25B | 17.7 | 80.78% |
| TWST | Twist Bioscience Corporation | 127.22 | 0.29% | 7.92B | — | 301.07% |
| SYRE | Spyre Therapeutics, Inc. | 90.60 | 2.13% | 7.87B | — | 176.56% |
| IMVT | Immunovant, Inc. | 37.36 | -1.94% | 7.71B | — | 46.97% |
| RYTM | Rhythm Pharmaceuticals, Inc. | 104.71 | 2.46% | 7.18B | — | -2.18% |
| BLTE | Belite Bio, Inc | 173.79 | -0.73% | 6.97B | — | 8.65% |
| CAI | Caris Life Sciences, Inc. | 24.34 | 1.25% | 6.88B | 65.4 | -9.79% |
| SRRK | Scholar Rock Holding Corporation | 55.41 | -0.47% | 6.64B | — | 25.79% |
| CGON | CG Oncology Inc. | 72.35 | 0.49% | 6.38B | — | 74.25% |
| CNTA | Centessa Pharmaceuticals plc | 40.50 | 0.00% | 6.27B | — | 61.94% |
| TVTX | Travere Therapeutics, Inc. | 66.17 | -1.98% | 6.15B | — | 73.17% |
| MIRM | Mirum Pharmaceuticals, Inc. | 98.22 | -2.38% | 5.99B | — | 24.34% |
| DNTH | Dianthus Therapeutics, Inc. | 106.20 | 2.83% | 5.94B | — | 157.70% |
| COGT | Cogent Biosciences, Inc. | 33.41 | -1.97% | 5.71B | — | -5.94% |
| LGND | Ligand Pharmaceuticals Incorporated | 284.47 | -1.65% | 5.70B | 28.4 | 50.46% |
| XENE | Xenon Pharmaceuticals Inc. | 58.65 | -0.26% | 5.67B | — | 30.86% |
| ORKA | Oruka Therapeutics, Inc. | 92.38 | 0.80% | 5.57B | — | 204.78% |
| PTCT | PTC Therapeutics, Inc. | 66.06 | -1.94% | 5.51B | — | -13.03% |
| ERAS | Erasca, Inc. | 15.88 | -0.94% | 5.51B | — | 326.88% |
| DFTX | Definium Therapeutics, Inc. | 38.89 | 3.07% | 5.16B | — | 190.44% |
| CRSP | CRISPR Therapeutics AG | 51.72 | -1.03% | 4.99B | — | -1.37% |
| EWTX | Edgewise Therapeutics, Inc. | 44.40 | 3.50% | 4.78B | — | 78.89% |
| ACAD | ACADIA Pharmaceuticals Inc. | 27.83 | 0.32% | 4.77B | 12.4 | 4.19% |
| PRTC | PureTech Health plc | 17.42 | 1.99% | 4.23B | — | 4.45% |
| RLAY | Relay Therapeutics, Inc. | 18.87 | -0.11% | 4.14B | — | 123.05% |
| MANE | Veradermics, Incorporated | 98.97 | 0.85% | 4.13B | — | 191.09% |
| CELC | Celcuity Inc. | 83.45 | -2.39% | 4.07B | — | -16.33% |
| ELVN | Enliven Therapeutics, Inc. | 54.32 | -3.40% | 3.88B | — | 252.73% |
| ADPT | Adaptive Biotechnologies Corporation | 24.20 | -0.12% | 3.87B | — | 49.01% |
| TNGX | Tango Therapeutics, Inc. | 23.78 | 1.75% | 3.87B | — | 168.40% |
| CPRX | Catalyst Pharmaceuticals, Inc. | 31.49 | 0.00% | 3.85B | 17.5 | 34.92% |
| IOVA | Iovance Biotherapeutics, Inc. | 8.60 | 5.65% | 3.84B | — | 215.02% |
| TLX | Telix Pharmaceuticals Limited | 11.29 | -5.13% | 3.81B | 113.4 | 50.73% |
| VKTX | Viking Therapeutics, Inc. | 31.98 | -0.47% | 3.73B | — | -9.10% |
| IDYA | IDEAYA Biosciences, Inc. | 37.59 | 0.37% | 3.57B | — | 8.74% |
| AMLX | Amylyx Pharmaceuticals, Inc. | 31.62 | -1.46% | 3.52B | — | 161.75% |
| LEGN | Legend Biotech Corporation | 18.64 | -2.87% | 3.45B | — | -14.26% |
| TARS | Tarsus Pharmaceuticals, Inc. | 79.31 | -2.23% | 3.41B | — | -3.14% |
| DYN | Dyne Therapeutics, Inc. | 18.21 | -1.14% | 3.40B | — | -6.90% |
| DNLI | Denali Therapeutics Inc. | 21.09 | -1.45% | 3.35B | — | 27.74% |
| ABCL | AbCellera Biologics Inc. | 10.89 | 4.11% | 3.33B | — | 218.42% |
| RCUS | Arcus Biosciences, Inc. | 24.59 | -5.97% | 3.09B | — | 3.19% |
| QURE | uniQure N.V. | 44.51 | 0.09% | 3.09B | — | 86.00% |
| ARQT | Arcutis Biotherapeutics, Inc. | 23.89 | 2.18% | 2.99B | 108.2 | -17.73% |
| MBX | MBX Biosciences, Inc. Common Stock | 59.02 | -3.15% | 2.81B | — | 87.13% |
| ZLAB | Zai Lab Limited | 24.14 | -0.12% | 2.73B | — | 36.85% |
| ATAI | Atai Beckley Inc. | 7.35 | 0.82% | 2.72B | — | 79.71% |
| IRON | Disc Medicine, Inc. | 70.06 | -5.50% | 2.69B | — | -11.77% |
| NAMS | NewAmsterdam Pharma Company N.V. | 22.80 | 4.30% | 2.67B | — | -35.01% |
| PHVS | Pharvaris N.V. | 38.02 | 1.36% | 2.66B | — | 37.01% |
| NRIX | Nurix Therapeutics, Inc. | 25.10 | -2.75% | 2.60B | — | 32.31% |
| VERA | Vera Therapeutics, Inc. | 35.05 | 4.32% | 2.52B | — | -30.79% |
| MLYS | Mineralys Therapeutics, Inc. | 28.20 | -3.75% | 2.49B | — | -22.29% |
| BEAM | Beam Therapeutics Inc. | 23.99 | -1.56% | 2.47B | — | -13.46% |
| CLDX | Celldex Therapeutics, Inc. | 36.90 | -3.15% | 2.46B | — | 35.86% |
| PGEN | Precigen, Inc. | 6.85 | 2.54% | 2.44B | — | 63.88% |
| VRDN | Viridian Therapeutics, Inc. | 21.24 | -4.71% | 2.41B | — | -31.75% |
| HRMY | Harmony Biosciences Holdings, Inc. | 41.52 | 1.02% | 2.40B | 13.3 | 10.96% |
| IMNM | Immunome, Inc. | 24.67 | -1.20% | 2.36B | — | 14.85% |
| OCUL | Ocular Therapeutix, Inc. | 10.49 | -1.22% | 2.30B | — | -13.59% |
| TRVI | Trevi Therapeutics, Inc. | 15.90 | -0.06% | 2.26B | — | 27.00% |
| GPCR | Structure Therapeutics Inc. | 38.66 | -2.25% | 2.23B | — | -44.41% |
| SRPT | Sarepta Therapeutics, Inc. | 20.45 | -0.34% | 2.16B | — | -4.97% |
| PVLA | Palvella Therapeutics, Inc. | 150.13 | -0.17% | 2.15B | — | 43.43% |
| SLS | SELLAS Life Sciences Group, Inc. | 11.55 | -14.38% | 2.15B | — | 206.37% |
| ADMA | ADMA Biologics, Inc. | 9.23 | -1.70% | 2.14B | 12.8 | -49.40% |
| NUVB | Nuvation Bio Inc. | 6.07 | -3.34% | 2.11B | — | -32.25% |
| RAPP | Rapport Therapeutics, Inc. Common Stock | 43.62 | 0.37% | 2.09B | — | 43.77% |
| AUPH | Aurinia Pharmaceuticals Inc. | 16.10 | -0.06% | 2.07B | 6.8 | 0.94% |
| BCRX | BioCryst Pharmaceuticals, Inc. | 8.12 | -2.05% | 2.06B | — | 4.10% |
| URGN | UroGen Pharma Ltd. | 42.31 | 0.17% | 2.06B | — | 80.66% |
| KOD | Kodiak Sciences Inc. | 32.89 | 0.06% | 2.06B | — | 17.63% |
| GENB | Generate Biomedicines, Inc. | 15.72 | 2.14% | 2.02B | — | 4.80% |
| AGIO | Agios Pharmaceuticals, Inc. | 33.60 | -0.12% | 2.01B | — | 23.44% |
| NKTR | Nektar Therapeutics | 69.76 | -1.26% | 2.00B | — | 65.00% |
| MESO | Mesoblast Limited | 15.48 | -0.13% | 2.00B | — | -14.19% |
| ZBIO | Zenas BioPharma, Inc. | 31.12 | 0.06% | 1.96B | — | -14.29% |
| VCEL | Vericel Corporation | 38.34 | 1.24% | 1.96B | 79.9 | 6.47% |
| CMPS | COMPASS Pathways plc | 14.35 | 0.91% | 1.94B | — | 107.97% |
| ZYME | Zymeworks Inc. | 26.24 | -0.76% | 1.93B | — | -0.34% |
| BHVN | Biohaven Ltd. | 12.71 | -0.63% | 1.91B | — | 12.58% |
| STOK | Stoke Therapeutics, Inc. | 29.03 | -1.06% | 1.87B | — | -8.54% |
| GHRS | GH Research PLC | 27.20 | -0.29% | 1.86B | — | 114.17% |
| NBTX | Nanobiotix S.A. | 37.01 | -1.57% | 1.84B | — | 60.08% |
| XNCR | Xencor, Inc. | 24.41 | 0.62% | 1.81B | — | 59.44% |
| KLRA | Kailera Therapeutics, Inc. | 13.94 | -6.51% | 1.81B | — | -46.38% |
| MRVI | Maravai LifeSciences Holdings, Inc. | 6.53 | -2.97% | 1.80B | — | 100.92% |
| VIR | Vir Biotechnology, Inc. | 10.62 | 0.38% | 1.79B | — | 76.12% |
| LKFT | Lakefront Biotherapeutics N.V. | 26.81 | 0.00% | 1.77B | 2.6 | -18.01% |
| SEPN | Septerna Inc | 38.51 | 2.01% | 1.74B | — | 38.13% |
| DMRA | Damora Therapeutics, Inc. | 28.10 | 4.69% | 1.73B | — | 22.12% |
| RXRX | Recursion Pharmaceuticals, Inc. | 3.20 | 1.27% | 1.68B | — | -21.76% |
| IMCR | Immunocore Holdings plc | 32.60 | -2.92% | 1.66B | — | -6.08% |
| NTLA | Intellia Therapeutics, Inc. | 11.74 | -1.59% | 1.64B | — | 30.59% |
| FTRE | Fortrea Holdings Inc. | 17.20 | 1.06% | 1.64B | — | -0.29% |
| SNDX | Syndax Pharmaceuticals, Inc. | 18.18 | -3.40% | 1.61B | — | -13.47% |
| TSHA | Taysha Gene Therapies, Inc. | 5.02 | -2.71% | 1.61B | — | -8.73% |
| INBX | Inhibrx Biosciences Inc. | 109.27 | -1.93% | 1.60B | — | 38.32% |
| ANAB | AnaptysBio, Inc. | 53.87 | -2.34% | 1.60B | — | 66.68% |
| NVAX | Novavax, Inc. | 9.42 | 1.29% | 1.55B | — | 40.18% |
| INVA | Innoviva, Inc. | 20.66 | 0.19% | 1.52B | 4.2 | 3.35% |
| BCAX | Bicara Therapeutics Inc. Common Stock | 22.81 | -1.26% | 1.50B | — | 35.53% |
| AAPG | Ascentage Pharma Group International | 16.10 | -3.42% | 1.50B | — | -38.64% |
| AVLN | Avalyn Pharma Inc. Common Stock | 33.57 | -3.17% | 1.49B | — | 29.12% |
| KALV | KalVista Pharmaceuticals, Inc. | 27.00 | 0.00% | 1.44B | — | 67.18% |
| RARE | Ultragenyx Pharmaceutical Inc. | 14.30 | -0.69% | 1.41B | — | -37.83% |
| ABSI | Absci Corporation | 8.21 | -0.36% | 1.39B | — | 135.24% |
| MAZE | Maze Therapeutics, Inc. | 24.60 | -0.89% | 1.36B | — | -40.62% |
| AVBP | ArriVent BioPharma, Inc. | 29.00 | 1.05% | 1.35B | — | 44.14% |
| OMER | Omeros Corporation | 18.28 | -1.67% | 1.32B | 9.6 | 6.40% |
| TYRA | Tyra Biosciences, Inc. | 22.03 | -6.41% | 1.31B | — | -16.20% |
| DRTS | Alpha Tau Medical Ltd | 14.43 | -0.07% | 1.30B | — | 191.52% |
| XERS | Xeris Biopharma Holdings, Inc. | 7.45 | -2.87% | 1.29B | — | -5.10% |
| LBRX | LB Pharmaceuticals Inc Common Stock | 44.63 | -3.50% | 1.28B | — | 100.49% |
| TRAX | First Tracks Biotherapeutics Inc | 36.44 | -4.05% | 1.27B | — | 77.67% |
| CGEM | Cullinan Therapeutics, Inc. | 20.59 | -1.95% | 1.27B | — | 98.94% |
| SPTX | Seaport Therapeutics, Inc. Common Stock | 23.34 | 0.26% | 1.25B | — | 11.14% |
| ORIC | ORIC Pharmaceuticals, Inc. | 12.04 | -0.25% | 1.25B | — | 47.19% |
| AKTS | Aktis Oncology, Inc. | 23.30 | -2.67% | 1.24B | — | -13.70% |
| MNKD | MannKind Corporation | 3.75 | -1.06% | 1.20B | — | -33.86% |
| GLUE | Monte Rosa Therapeutics, Inc. | 14.07 | -1.75% | 1.19B | — | -10.27% |
| MGTX | MeiraGTx Holdings plc | 12.79 | -0.47% | 1.18B | 16.8 | 60.88% |
| ODTX | Odyssey Therapeutics, Inc. | 24.63 | 4.19% | 1.18B | — | 23.15% |
| IMTX | Immatics N.V. | 8.79 | 0.46% | 1.18B | — | -16.29% |
| ALMS | Alumis Inc. | 9.18 | -7.27% | 1.13B | — | -5.94% |
| ANRO | Alto Neuroscience, Inc. | 32.00 | 1.01% | 1.12B | — | 79.78% |
| JBIO | Jade Biosciences, Inc. | 17.89 | -6.53% | 1.09B | — | 15.94% |
| SVRA | Savara Inc. | 5.30 | -0.38% | 1.09B | — | -12.11% |
| REPL | Replimune Group, Inc. | 12.92 | -2.42% | 1.09B | — | 32.92% |
| CRVS | Corvus Pharmaceuticals, Inc. | 12.91 | -0.23% | 1.09B | — | 67.66% |
| MLTX | MoonLake Immunotherapeutics | 12.51 | -5.08% | 1.05B | — | -5.08% |
| JANX | Janux Therapeutics, Inc. | 17.10 | -3.28% | 1.04B | — | 23.91% |
| ABUS | Arbutus Biopharma Corp | 5.12 | 0.00% | 1.01B | 6.5 | 6.44% |
| KURA | Kura Oncology, Inc. | 11.39 | -1.56% | 1.01B | — | 9.62% |
| SGP | SpyGlass Pharma, Inc. Common Stock | 27.52 | 0.77% | 920.09M | — | 14.67% |
| DSGN | Design Therapeutics, Inc. | 14.63 | -1.15% | 913.75M | — | 55.97% |
| WVE | Wave Life Sciences Ltd. | 4.59 | -1.71% | 904.45M | — | -73.00% |
| OLMA | Olema Pharmaceuticals, Inc. | 10.22 | -4.40% | 892.69M | — | -59.12% |
| LXRX | Lexicon Pharmaceuticals, Inc. | 2.00 | -0.99% | 888.39M | — | 73.91% |
| ARDX | Ardelyx, Inc. | 3.58 | -1.10% | 884.36M | — | -38.59% |
| TBPH | Theravance Biopharma Inc | 17.01 | -0.06% | 881.60M | 16.0 | -9.09% |
| RIGL | Rigel Pharmaceuticals, Inc. | 47.24 | -0.08% | 874.04M | 2.7 | 10.30% |
| SANA | Sana Biotechnology, Inc. | 3.13 | 1.29% | 871.05M | — | -23.10% |
| GERN | Geron Corporation | 1.35 | -1.46% | 866.05M | — | 2.27% |
| SLDB | Solid Biosciences Inc. | 8.70 | -4.08% | 856.51M | — | 54.26% |
| CLYM | Climb Bio, Inc. | 14.25 | -4.68% | 816.00M | — | 256.25% |
| ANL | Adlai Nortye Ltd. | 15.21 | 0.80% | 807.35M | — | 971.13% |
| CADL | Candel Therapeutics, Inc. | 10.55 | -6.88% | 772.63M | — | 86.73% |
| PHAR | Pharming Group N.V. | 11.21 | 3.70% | 761.18M | 73.2 | -36.56% |
| GYRE | Gyre Therapeutics, Inc. | 6.73 | -0.15% | 750.32M | — | -4.67% |
| ACRS | Aclaris Therapeutics, Inc. | 5.32 | -3.45% | 743.01M | — | 76.74% |
| MNPR | Monopar Therapeutics Inc. | 110.26 | 0.27% | 738.64M | — | 68.85% |
| ACHV | Achieve Life Sciences, Inc. | 7.06 | -3.02% | 724.77M | — | 42.05% |
| AURA | Aura Biosciences, Inc. | 7.00 | 0.14% | 723.54M | — | 28.44% |
| CBIO | Crescent Biopharma, Inc. | 19.41 | -0.26% | 720.96M | — | 63.66% |
| CTMX | CytomX Therapeutics, Inc. | 3.29 | -1.79% | 716.24M | — | -22.77% |
| ZVRA | Zevra Therapeutics, Inc. | 12.01 | -0.41% | 709.97M | 12.5 | 34.04% |
| FDMT | 4D Molecular Therapeutics, Inc. | 13.17 | -2.37% | 688.48M | — | 75.60% |
| PHAT | Phathom Pharmaceuticals, Inc. | 8.36 | -0.12% | 676.33M | — | -49.61% |
| MDXG | MiMedx Group, Inc. | 4.57 | -0.65% | 666.13M | 114.3 | -32.50% |
| ESPR | Esperion Therapeutics, Inc. | 3.18 | 0.00% | 661.15M | — | -14.05% |
| IMMX | Immix Biopharma, Inc. | 12.14 | -4.41% | 660.44M | — | 132.12% |
| ANNX | Annexon, Inc. | 3.94 | -4.83% | 645.54M | — | -21.51% |
| AGMB | AgomAb Therapeutics N.V. American Depositary Shares | 13.06 | -6.31% | 643.22M | — | -11.16% |
| VALN | Valneva SE | 6.66 | -0.45% | 635.46M | — | -24.49% |
| DRUG | Bright Minds Biosciences Inc. | 63.18 | -2.80% | 623.84M | — | -19.04% |
| SLN | Silence Therapeutics plc | 13.02 | -2.18% | 614.99M | — | 114.14% |
| ALLO | Allogene Therapeutics, Inc. | 1.78 | 1.14% | 614.38M | — | 29.93% |
| CRMD | CorMedix Inc. | 7.83 | -1.63% | 613.89M | 3.2 | -32.67% |
| PROK | ProKidney Corp. | 1.80 | -2.17% | 605.26M | — | -19.64% |
| OCS | Oculis Holding AG | 10.56 | -6.63% | 603.61M | — | -47.12% |
| ASMB | Assembly Biosciences, Inc. | 29.80 | -2.17% | 590.55M | 54.2 | -12.38% |
| PRME | Prime Medicine, Inc. | 3.13 | -6.57% | 565.33M | — | -9.80% |
| NGNE | Neurogene Inc. | 35.48 | -1.77% | 560.67M | — | 72.23% |
| CTNM | Contineum Therapeutics, Inc. | 14.82 | 1.09% | 557.55M | — | 29.66% |
| TECX | Tectonic Therapeutic, Inc. | 29.05 | 1.54% | 548.15M | — | 39.26% |
| ARVN | Arvinas, Inc. | 8.45 | -2.99% | 545.20M | 44.5 | -28.75% |
| XOMA | XOMA Royalty Corp. | 40.17 | 0.00% | 503.77M | 24.3 | 51.07% |
| AUTL | Autolus Therapeutics plc | 1.88 | -4.08% | 500.35M | — | -5.53% |
| IRD | Opus Genetics, Inc. | 6.04 | -0.49% | 498.70M | — | 200.50% |
| CAPR | Capricor Therapeutics, Inc. | 8.37 | 0.84% | 481.36M | — | -71.00% |
| RLMD | Relmada Therapeutics, Inc. | 4.52 | 11.06% | 474.10M | — | -6.42% |
| SPRY | ARS Pharmaceuticals, Inc. | 4.76 | -5.93% | 472.68M | — | -59.14% |
| PRTA | Prothena Corporation plc | 8.93 | -1.00% | 467.51M | — | -6.49% |
| PBYI | Puma Biotechnology, Inc. | 9.12 | -0.55% | 464.20M | 17.0 | 53.28% |
| CABA | Cabaletta Bio, Inc. | 2.73 | -0.36% | 445.14M | — | 24.66% |
| KYTX | Kyverna Therapeutics, Inc. | 7.26 | -1.22% | 441.37M | — | -22.77% |
| RGNX | REGENXBIO Inc. | 8.53 | -0.35% | 440.98M | — | -40.76% |
| DNA | Ginkgo Bioworks Holdings, Inc. | 6.75 | -0.44% | 440.94M | — | -18.77% |
| AVIR | Atea Pharmaceuticals, Inc. | 5.31 | 2.51% | 424.94M | — | 48.74% |
| DBVT | DBV Technologies S.A. | 11.85 | -8.64% | 411.58M | — | -38.18% |
| RZLT | Rezolute, Inc. | 4.22 | 1.20% | 406.35M | — | 78.81% |
| BBOT | BridgeBio Oncology Therapeutics Inc. | 4.95 | -10.33% | 396.53M | — | -60.46% |
| EYPT | EyePoint Pharmaceuticals, Inc. | 4.23 | -0.47% | 354.65M | — | -76.85% |
| KROS | Keros Therapeutics, Inc. | 11.08 | -0.81% | 354.54M | — | -45.58% |
| SION | Sionna Therapeutics, Inc. | 7.85 | 3.02% | 354.43M | — | -80.92% |
| OCGN | Ocugen, Inc. | 1.02 | 0.00% | 345.89M | — | -24.44% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | 4.25 | -2.52% | 333.72M | — | -57.20% |
| XFOR | X4 Pharmaceuticals, Inc. | 3.50 | 2.94% | 330.12M | — | -12.50% |
| BIOA | BioAge Labs Inc. | 8.49 | -1.85% | 319.65M | — | -35.83% |
| ABEO | Abeona Therapeutics Inc. | 5.42 | -1.09% | 308.63M | — | 2.85% |
| VNDA | Vanda Pharmaceuticals Inc. | 5.09 | 0.99% | 306.09M | — | -42.29% |
| GLSI | Greenwich LifeSciences, Inc. | 15.45 | 2.59% | 226.78M | — | -26.46% |
| VRXA | Veraxa Biotech Holding AG | 1.65 | 0.00% | 55.66M | — | -88.21% |